View : 90 Download: 0

Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator

Title
Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator
Authors
MinSe HeeSongDo KyeongLeeChan HeeRohEunKimMin-Seon
Ewha Authors
송도경
SCOPUS Author ID
송도경scopus
Issue Date
2024
Journal Title
Endocrinology and Metabolism
ISSN
2093-596XJCR Link
Citation
Endocrinology and Metabolism vol. 39, no. 1, pp. 1 - 11
Keywords
AMP-activated protein kinasesEnergy metabolismGlucose metabolismHormonesHypothalamus
Publisher
Korean Endocrine Society
Indexed
SCIE; SCOPUS; KCI WOS scopus
Document Type
Article
Abstract
5´-Adenosine monophosphate (AMP)-activated protein kinase (AMPK), a cellular energy sensor, is an essential enzyme that helps cells maintain stable energy levels during metabolic stress. The hypothalamus is pivotal in regulating energy balance within the body. Certain neurons in the hypothalamus are sensitive to fluctuations in food availability and energy stores, triggering adaptive responses to preserve systemic energy equilibrium. AMPK, expressed in these hypothalamic neurons, is instrumental in these regulatory processes. Hypothalamic AMPK activity is modulated by key metabolic hormones. Anorexigenic hormones, including leptin, insulin, and glucagon-like peptide 1, suppress hypothalamic AMPK activity, whereas the hunger hormone ghrelin activates it. These hormonal influences on hypothalamic AMPK activity are central to their roles in controlling food consumption and energy expenditure. Additionally, hypothalamic AMPK activity responds to variations in glucose concentrations. It becomes active during hypoglycemia but is deactivated when glucose is introduced directly into the hypothalamus. These shifts in AMPK activity within hypothalamic neurons are critical for maintaining glucose balance. Considering the vital function of hypothalamic AMPK in the regulation of overall energy and glucose balance, developing chemical agents that target the hypothalamus to modulate AMPK activity presents a promising therapeutic approach for metabolic conditions such as obesity and type 2 diabetes mellitus. Copyright © 2024 Korean Endocrine Society.
DOI
10.3803/EnM.2024.1922
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE